Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other Accumulated Expenses: 2015-2022

Historic Other Accumulated Expenses for Editas Medicine (EDIT) over the last 8 years, with Dec 2022 value amounting to $1.6 million.

  • Editas Medicine's Other Accumulated Expenses fell 97.18% to $78,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $78,000, marking a year-over-year decrease of 97.18%. This contributed to the annual value of $1.6 million for FY2022, which is 16.12% up from last year.
  • Per Editas Medicine's latest filing, its Other Accumulated Expenses stood at $1.6 million for FY2022, which was up 16.12% from $1.4 million recorded in FY2021.
  • In the past 5 years, Editas Medicine's Other Accumulated Expenses ranged from a high of $2.7 million in FY2019 and a low of $1.1 million during FY2020.
  • In the last 3 years, Editas Medicine's Other Accumulated Expenses had a median value of $1.4 million in 2021 and averaged $1.4 million.
  • In the last 5 years, Editas Medicine's Other Accumulated Expenses surged by 127.56% in 2018 and then slumped by 57.87% in 2020.
  • Over the past 5 years, Editas Medicine's Other Accumulated Expenses (Yearly) stood at $2.0 million in 2018, then skyrocketed by 30.96% to $2.7 million in 2019, then tumbled by 57.87% to $1.1 million in 2020, then climbed by 24.60% to $1.4 million in 2021, then increased by 16.12% to $1.6 million in 2022.